| output_id | display_id | version | name | displayTitle | sectionType | order | subSection_id | subSection_text | subSectionId | Out14-1 |
|---|
| Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Title | 1 | GlobalDisp_Title_1 | Study CDISCPILOT01 | GlobalDisp_Title_1 |
| Out14-1 | Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Title | 2 | Disp14-1-1_Title_1 | Table 14.1.1 |
|
| Out14-1 | Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Title | 3 | Disp14-1-1_Title_2 | Summary of Demographics |
|
| Out14-1 | Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Title | 4 | Disp14-1-1_Title_3 | Male Subjects |
|
| Out14-1 | Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Footnote | 1 | Disp14-1-1_Fnote_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MMOut14-1 |
|
| Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Rowlabel Header | 1 | Disp14-1-1_RLbHd_1 | Characteristics |
|
| Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Title | 1 | GlobalDisp_Title_1 | Study CDISCPILOT01 | GlobalDisp_Title_1Out14-1 |
| Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Title | 2 | Disp14-1-2_Title_1 | Table 14.1.2 |
|
| Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Title | 3 | Disp14-1-1_Title_2 | Summary of Demographics | Disp14-1-1_Title_2 |
| Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Title | 4 | Disp14-1-2_Title_2 | Female Subjects |
|
| Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Footnote | 1 | Disp14-1-1_Fnote_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MM | Disp14-1-1_Fnote_1 |
| Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Rowlabel Header | 1 | Disp14-1-1_RLbHd_1 | Characteristics | Out14-3-1-1 |
|
| Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 1 | GlobalDisp_Title_1 | Study CDISCPILOT01 | GlobalDisp_Title_1Out14-3-1-1 |
| Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 2 | Disp14-3-1-1_Title_1 | Table 14.3.1.1 |
|
| Out14-3-1-1 | Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 3 | Disp14-3-1-1_Title_2 | Overall Summary of Treatment-Emergent Adverse EventsOut14-3-1-1 |
|
| Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Abbreviation | 1 | Disp14-3-1-1_Abbrv_1 | Note: TEAE=Treatment-Emergent Adverse Events.Out14-3-1-1 |
|
| Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Footnote | 1 | Disp14-3-1-1_Fnote_1 | [a] Dose Modification includes Dose Reduced; Drug Interrupted in the AE action taken with study treatment. |
|
| Out14-3-1-1 | Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Footnote | 2 | Disp14-3-1-1_Fnote_2 | Source dataset: adae, Generated on: DDMONYYYY:HH:MMOut14-3-1-1 |
|
| Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Rowlabel Header | 1 | Disp14-3-1-1_RLbHd_1 | Categories, n (%) |
|